Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Outset Medical (Nasdaq: OM) announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Outset Medical (Nasdaq: OM) announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 4:30 p.m. PT. A live webcast and archived replay will be available in the Investors section of Outset Medical's website at https://investors.outsetmedical.com/.
This presentation offers investors a scheduled opportunity to hear company updates directly from management and access a recorded webcast for later review.
Details
News Market Reaction – OM
On Jan 6, the first trading day after this news, OM closed 12.89% above the previous close.
Data tracked by StockTitan Argus for the Jan 6 session.
Key Figures
- Conference edition
- 44th annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 14, 2026
- J.P. Morgan Healthcare Conference
- Presentation time
- 4:30 p.m. Pacific
- J.P. Morgan Healthcare Conference
- Current price
- $3.70
- Before J.P. Morgan conference news
- 52-week range
- $3.10 – $25.35
- Pre‑news trading range
- Market cap
- $67,347,964
- Pre‑news valuation
- 20-day avg volume
- 503,706 shares
- Liquidity benchmark before conference news
- Today’s volume
- 244,294 shares
- Sub‑average trading ahead of conference
Historical Context
-
Q3 2025 results with modest growth and lowered full‑year revenue guidance.
-
New research from 1M+ Tablo treatments showing improved safety and satisfaction.
-
Planned presentation at the 2025 Stifel Healthcare Conference with webcast access.
-
Announcement of timing and access details for Q3 2025 earnings release and call.
-
Collaboration with Northwest Kidney Centers to expand home hemodialysis using Tablo.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on Wednesday, January 14, 2026, at 4:30 p.m. Pacific time.
A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.
Contact
Jim Mazzola
Vice President, Investor Relations
jmazzola@outsetmedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.